Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CytomX Therapeutics, Inc. - Common Stock (NQ:CTMX)

4.210 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,063
Open 4.210
Bid (Size) 4.400 (1,200)
Ask (Size) 4.430 (700)
Prev. Close 4.210
Today's Range 4.210 - 4.210
52wk Range 0.4000 - 4.455
Shares Outstanding 66,767,779
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Intuit, Workday And Other Big Stocks Moving Lower In Friday's Pre-Market Session
 
Via Benzinga

Performance

YTD
+297.2%
+297.2%
1 Month
+28.4%
+28.4%
3 Month
+94.0%
+94.0%
6 Month
+338.3%
+338.3%
1 Year
+324.0%
+324.0%

More News

Read More
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
CytomX (CTMX) Q2 Revenue Drops 26%
Via The Motley Fool
Topics Intellectual Property
Earnings Scheduled For August 7, 2025
Via Benzinga
Earnings Scheduled For November 6, 2025
Via Benzinga
CytomX Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Via Benzinga
Why CytomX Therapeutics Stock Was Skyrocketing This Week
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
What's going on in today's after hours session
Via Chartmill
CytomX Therapeutics Inc (NASDAQ:CTMX) Reports Q2 2025 Revenue Beat and Break-Even EPS
Via Chartmill
This Lexeo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday
Via Benzinga
Deep Dive Into CytomX Therapeutics Stock: Analyst Perspectives (4 Ratings)
Via Benzinga
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
Via Investor Brand Network
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
Via FinancialNewsMedia
Topics Death
CYTOMX THERAPEUTICS INC (NASDAQ:CTMX) - A Strong Contender in High-Growth Biotech
Via Chartmill
Heico, Monro, Abercrombie & Fitch, Joby Aviation And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
CytomX Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Via Benzinga
This CytomX Therapeutics Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday
Via Benzinga
CytomX Stock Hits 2-Month High After Upbeat Q1 Earnings, Promising Early Data For Cancer Drug
Via Stocktwits
Top movers analysis one hour before the close of the markets on 2025-05-12: top gainers and losers in today's session.
Via Chartmill
Monday's session: most active stocks
Via Chartmill
Stocks Under $1 to Watch: TAOP, WLGS, HIT, CTMX, JYD – Major Updates, Earnings & Offerings, More Inside….
Via AB Newswire
Topics Economy
Which stocks are moving on Monday?
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga

Frequently Asked Questions

Is CytomX Therapeutics, Inc. - Common Stock publicly traded?
Yes, CytomX Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does CytomX Therapeutics, Inc. - Common Stock trade on?
CytomX Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CytomX Therapeutics, Inc. - Common Stock?
The ticker symbol for CytomX Therapeutics, Inc. - Common Stock is CTMX on the Nasdaq Stock Market
What is the current price of CytomX Therapeutics, Inc. - Common Stock?
The current price of CytomX Therapeutics, Inc. - Common Stock is 4.210
When was CytomX Therapeutics, Inc. - Common Stock last traded?
The last trade of CytomX Therapeutics, Inc. - Common Stock was at 11/05/25 04:00 PM ET
What is the market capitalization of CytomX Therapeutics, Inc. - Common Stock?
The market capitalization of CytomX Therapeutics, Inc. - Common Stock is 281.09M
How many shares of CytomX Therapeutics, Inc. - Common Stock are outstanding?
CytomX Therapeutics, Inc. - Common Stock has 281M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.